Randomized trial evaluates implant stability in patients with Er:YAG laser biomodification, suggesting improved outcomes.
Background: Er:YAG laser (λ = 2940 nm) biomodification of the implant osteotomy site removes the smear layer after rotary preparation and may enhance bone-implant contact. This randomized controlled clinical study evaluated implant stability dynamics following Er:YAG laser biomodification using resonance frequency analysis (RFA). Methods: Ninety patients were randomized 1:1 into a case group (n = 45; rotary osteotomy + Er:YAG biomodification; 400 mJ, 17 Hz) and a control group (n = 45; rotary osteotomy alone). Implant stability quotient (ISQ) was measured by RFA in vestibulo-oral (VO) and mesiodistal (MD) directions at placement, days 10, 20, 30, and month 3. Results: The case group showed significantly higher ISQ values at all time points in both directions (t-test, p < 0.05). Repeated measures ANOVA revealed a significant time × group interaction in the MD direction (F = 14.461, p < 0.001, partial η2 = 0.341). Primary VO ISQ: 75.04 ± 4.27 (cases) vs. 72.29 ± 3.38 (controls); primary MD ISQ: 76.49 ± 4.29 vs. 72.89 ± 2.29. The proportion achieving ISQ ≥ 70 was consistently higher in the case group. Conclusions: Er:YAG laser biomodification combined with rotary osteotomy yields higher, more stable ISQ values throughout early healing in mandibular D2/D3 bone, potentially supporting shorter healing intervals and early loading in selected clinical situations.
No takes yet. Share an insight, caveat, or question.
Kanazirski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: